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Abstract: The Danish National Diabetes Register (NDR) was established in 2006 and builds 
on data from Danish health registers. We validated the content of NDR, using full information 
from the Danish National Patient Register and data from the literature. Our study indicates 
that the completeness in NDR is $95% concerning ascertainment from data sources specific 
for diabetes, ie, prescriptions with antidiabetic drugs and diagnoses of diabetes in the National 
Patient Register. Since the NDR algorithm ignores diabetes-related hospital contacts terminated 
before 1990, the establishment of the date of inclusion is systematically delayed for $10% of 
the registrants in general and for $30% of the inclusions before 1997 in particular. This bias 
is enhanced for ascertainment by chiropody services and by frequent measurements of blood 
glucose because the date of reimbursement of services, rather than the date of encounter, has 
been taken as the date of inclusion in NDR. We also find that some 20% of the registrations in 
NDR may represent false positive inclusions of persons with frequent measurements of blood 
glucose without having diabetes. We conclude that NDR is a novel initiative to support research 
in the epidemiological and public health aspects of diabetes in Denmark, but we also present a 
list of recommended changes for improving validity, by reducing the impact of current sources 
of bias and misclassifications.
Keywords: diabetes mellitus, epidemiology, ascertainment, validity
Introduction
Like the other Nordic countries, Denmark offers unique opportunities for register-based 
research in epidemiology and health care.1,2 Denmark has a particularly strong tradi-
tion of epidemiological research in diabetes,3 which has been further enhanced with 
the establishment of the Danish National Diabetes Register (NDR) and the utilization 
of NDR for research purposes.4,5
We have previously used Danish health registers and population-based samples for 
studies of the epidemiological and public health aspects of diabetes.6,7 The establish-
ment of NDR represents a new source for access to individual patient data that we are 
currently making use of, within the framework of a project called the Diabetes Impact 
Study 2013, to update our previous studies.
A study that used supplementary methods to ascertain persons with diabetes was 
performed recently in parts of the former county of Vejle and found that clinical 
characteristics and mortality differed according to the ascertainment methods applied.8 
We present here a comprehensive validation analysis of NDR, as part of the Diabetes 
Impact Study 2013.
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Materials and methods
sources and content of nDr
NDR was established by the Danish National Board of 
Health in 2006 to provide a resource for monitoring the 
clinical course in patients with diabetes.4 NDR is built upon 
information from already existing Danish health registers, 
including the Danish National Patient Register (DNPaR),9 
the Danish National Prescription Registry,10 and the Danish 
National Health Service Register11 as well as the Danish 
Civil Registration System (DCRS).12 In addition, NDR 
extracts information from DCRS on residence (municipality 
code) for each registrant as well as recorded survival status. 
Linkage of person-specific data between the registers is 
possible using the person identification number (PIN) that 
is assigned to each Danish citizen at birth or when granted 
Danish citizenship. For persons without Danish citizenship 
but with a permission to stay in Denmark, a temporary PIN 
is assigned. The PIN is unique and used for administra-
tive purposes throughout the public and private sectors in 
Denmark, and is saved in the central health registers even 
after the death of the citizen.
Table 1 provides an overview, based on the account 
of Carstensen et al,4 of the main content of NDR, together 
with the data sources. The date that a given person is 
qualified for inclusion in NDR is known for each of the 
data sources (Table 1). The date of inclusion in NDR for a 
given person occurs when the first of any qualifying events 
(Table 1) for that person is fulfilled.
It should be noted that according to the detailed docu-
mentation, NDR ignores all hospital contacts terminated 
before 1990 in the search for diabetes-related activities in the 
DNPaR.13 Overall, the algorithms employed are assumed to 
identify persons with diabetes with a high level of probability 
and to reduce false positive inclusion of young women with 
polycystic ovarian syndrome and women with gestational 
diabetes. NDR is supposed to include all persons with inclu-
sion date since the start of 1997, as well as all persons who 
were alive at the end of 1996 and identified in the health 
registers with an inclusion date before 1997.
NDR is operated by the Statens Serum Institut and is 
updated on an annual basis, most recently by the inclusion 
of data for the year 2012. The content of NDR is available 
for research, provided permission is obtained from the 
Danish Data Protection Agency and the Danish National 
Board of Health.
supplementary data
The present analysis is based on the content of NDR, 
as extracted on July 3, 2013, containing the data on all 
inclusions in NDR until 2012. For all registered persons 
(n=497,232), data were extracted on all contacts (regardless 
of date) registered in DNPaR, containing information on all 
interventions performed, primary and secondary diagnoses 
underlying the contact, hospitalization, and all relevant dates.9 
The supplementary material presents a list of all diagnoses 
(according to International Classification of Disease [ICD]8 
and ICD10 classifications) and intervention codes (according 
to the official Danish classification of codes in healthcare) 
used for this extraction. It should be noted that the codes 
for diabetes related to pregnancy (ICD10 code DO24) were 
not used for the purpose of obtaining supplementary data. 
In addition, all available data on moves, migrations, and 
deaths recorded on the population of NDR registrants were 
obtained from DCRS.12
Methods of analysis
All inclusions in NDR were described by ascertainment 
source. For this purpose, ascertainment by means of a 
diagnosis of diabetes in DNPaR was labeled “DMdiag”. 
Ascertainment by frequency of blood glucose measure-
ments (“blod2i5” and “blod5i1”, respectively) was grouped 
to the ascertainment category “BSfreq” (Table 1). Similarly, 
ascertainment by means of purchased antidiabetic drugs 
Table 1 source registers and content of nDr
Source 
register
Item in NDR 
(label)
Inclusion algorithm
DnPar lpr (“DMdiag”) registration in DnPar with a 
diagnosis of diabetes, defined as 
iCD-10: DE10-14, Dh36.0, DO24 
(excluding DO24.4), and iCD-8 (prior 
to 1994): 249, 250
DnPrr ins (“antiDiab”) Purchase of insulin recorded at least 
twice in DnPrra
oad (“antiDiab”) Purchase of oad at least twice 
recorded in DnPrr.a an exception 
is females aged 20–39 prescribed 
metformin exclusively
Dnhsr blod5i1 (“Bsfreq”) Five blood glucose measurements in a 
1-year period in Dnhsr
blod2i5 (“Bsfreq”) Two blood glucose measurements per 
year in 5 consecutive years in Dnhsr
fodt (“Chiro”) registration of chiropody (as a service 
for a diabetic patient) in Dnhsr
Note: aInclusion criteria only fulfilled at purchase of second prescription of the drug.
Abbreviations: antiDiab, antidiabetic drug; Bsfreq, frequency of blood sugar 
measurement; Chiro, chiropody; DMdiag, diagnoses of diabetes; Dnhsr, Danish 
national health service register; DnPar, Danish national Patient register; DnPrr, 
Danish National Prescription Registry; ICD, International Classification of Diseases; 
ins, insulin; nDr, national Diabetes register; oad, oral antidiabetic drug.
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(“ins” and “oad”) was grouped to the ascertainment category 
“AntiDiab”. Ascertainment by receiving a service as a person 
with diabetes by a registered chiropodist was categorized as 
“Chiro”.
Using the access to the full information from DNPaR, 
we identified for each registrant in NDR, all hospital con-
tacts where diabetes formed part of the primary diagnosis 
or where interventions performed during the contact were 
specific for diabetes. The supplementary material contains 
the list of diagnostic codes (ICD8 classification for contacts 
before 1995; ICD10 classification for contacts for 2005 and 
forward) and the procedure codes specific for intervention in 
diabetes as used in all Danish hospitals. If such contacts were 
later than the inclusion date registered in NDR, the inclusion 
date in NDR was set operationally as the date of diagnosis 
of diabetes. If such contacts were earlier than the inclusion 
date registered in NDR, the earliest admission date was set 
operationally as the date of diagnosis.
Secondary ascertainment for a given patient occurred by 
the fulfillment of inclusion criteria by any other data sources 
than the first one. For each ascertainment, source methods 
for survival analysis14 were used to estimate the cumulative 
probability of being ascertained by the first occurring 
secondary source. Patients were censored if death occurred 
before experiencing secondary ascertainment.
All data were analyzed using anonymized PINs. Since 
this was a purely descriptive study without any prior speci-
fied hypotheses to be tested, only descriptive analyses were 
performed.
Ethical aspects
The Diabetes Impact Study 2013 is observational, with no 
contact to registered persons. Permission to extract and 
analyze data was obtained from the Danish Data Protection 
Agency (permit number Jnr 2013-21-1749) and the 
Danish National Board of Health (permit number FSEID-
00000440).
Results
ascertainment by source in nDr
Figure 1 provides an overview of the population of persons 
registered in NDR. In total, 688 persons (0.1%) have been 
excluded for various reasons. In particular, 530 persons 
with inclusion after death represent persons who died 
DMdiag:
n=149,939
(30.2%) 
AntiDiab:
n=109,991
(22.2%)
BSfreq:
n=187,921
(37.8%) 
Chiro:
n=48,663
(9.8%) 
Total number of persons included in NDR:
N=497,232
Number of persons included in analysis:
N=496,514 (99.9%)
Errors or irregularities in PIN:
n=127
Exit before last relevant DNPaR contact:
n=31
Date of inclusion after date of exit:
n=530
Figure 1 Flowchart of the population of persons registered as of July 3, 2013 in nDr.
Abbreviations: antiDiab, antidiabetic drug; Bsfreq, frequency of blood sugar measurement; Chiro, chiropody; DMdiag, diagnoses of diabetes; DnPar, Danish national 
Patient Register; NDR, National Diabetes Register; PIN, personal identification number.
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before inclusion. Further, 31 persons registered with a 
relevant contact in DNPaR after exit represent persons 
with date of emigration registered in DCRS before the 
event registered in DNPaR. Almost 40% of registrants are 
ascertained by “BSfreq” as the primary source, whereas 
less than 10% of the registrants are ascertained by “Chiro” 
as the primary source.
Trends over time in inclusion by primary ascertainment 
source are illustrated from 1997 and onward in Figure 2. 
The annual number of inclusions, representing registration 
incidence, has increased steadily, from about 15,000 to more 
than 30,000, over the period 1997 through 2011. A relatively 
large increase has been seen for primary ascertainment by 
“AntiDiab”, while the contribution from “DMdiag” has been 
rather constant and that for “BSfreq” has been modestly 
increasing. The number of inclusions by “Chiro” as the pri-
mary source is limited but shows relative increases during 
2002–2004 and again for the year 2011.
secondary ascertainment in nDr
Inclusion in NDR may be qualified in several ways, and 
registrants may have been ascertained subsequently by other 
sources than by the primary ascertainment source with the 
earliest qualification fulfilled. Figure 3 shows the cumulative 
probability of ascertainment by at least one additional source, 
by follow-up time from the date of primary ascertainment. 
This analysis uses inclusions from 1997 throughout 2011. 
The patterns of cumulative probability vary by primary 
ascertainment source. For primary ascertainment by both 
“DMdiag” and “AntiDiab”, some 80% of the persons will be 
ascertained by at least one additional source within a period 
of 10 years, however, with a sharper initial rise for persons 
primarily ascertained by “DMdiag”. Primary ascertainment 
by “Chiro” is associated with a cumulative probability at 
a lower level and with a more slow increase. For persons 
primarily ascertained by “BSfreq”, only about 50% will be 
ascertained by a second source and with only a modest initial 
sharp increase in the probability curve.
Operationally defined date  
of diagnosis of diabetes
Correspondence between the date of inclusion in NDR and 
the operationally defined date of diagnosis of diabetes, when 
using the full historical information in DNPaR, is shown in 
Table 2, grouped by period of inclusion in NDR. Overall, the 
operational date of diagnosis equals the date of inclusion in 
NDR for almost 89% of persons. However, the percentage 
with agreement is only about 68% for persons with inclusion 
before 1997 against about 98% for persons with inclusion from 
1997 and onward. The proportion of persons with more than 10 
years of difference from operationally defined date of diagnosis 
until inclusion in NDR is about 10% for inclusion before 1997 
against 0.4% for inclusion from 1997 and onward.
Discussion
NDR is a nationwide register that provides a unique platform 
for comprehensive research in the epidemiology and public 
health aspects of diabetes. As a main advantage, NDR makes 
35,000
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25,000
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5,000
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Figure 2 ascertainment in nDr by source and calendar time, for inclusions in nDr from 1997 through 2011.
Abbreviations: antiDiab, antidiabetic drug; Bsfreq, frequency of blood sugar measurement; Chiro, chiropody; DMdiag, diagnoses of diabetes; nDr, national Diabetes register.
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use of already existing data that are routinely collected and 
maintained at the national level. As a further advantage, NDR 
attempts to cover both the secondary and the primary health 
care sector. In the attempt to validate important elements of 
NDR, the present study has identified several areas of concern 
about the validity of NDR, some of which may be alleviated 
by simple measures.
Validity of ascertainment in nDr
Ascertainment by purchase of antidiabetic drugs and by a 
primary hospital discharge diagnosis of diabetes as well 
as by diabetes-related chiropody may be characterized as 
specific for diabetes. However, the present list of diagnoses 
used for the identification of diabetes-related contacts in 
DNPaR is not complete and should be supplemented with 
diagnostic codes for diabetic eye complications.  Furthermore, 
additional relevant contacts may be identified by codes of 
interventions specific for treatment of diabetes not included 
in the present NDR algorithm. Such codes may be identified 
by comparing the codes specified in Table 1 with the codes 
listed in the supplementary material. The use of such supple-
mentary codes may not increase the ascertainment in NDR 
substantially but may optimize the establishment of date of 
inclusion in NDR.
The inclusion of a substantial proportion of persons by 
means of the frequency of blood sugar measurements in the 
primary health care sector gives rise to concern about the 
validity of ascertainment, particularly because currently it 
is not possible to access information on the results of blood 
glucose measurements at the national level. Even though vali-
dation performed prior to the establishment of NDR indicated 
a high predictive value of diabetes for the “BSfreq” criteria 
currently used by NDR,4 increased awareness in diabetes 
may have changed clinical practice and thereby changed 
100
90
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50
40
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0
0 1 2 3 4 5 6 7
Follow-up (years) from inclusion in NDR
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8
Inclusion by DMdiag: N=93,114
Inclusion by AntiDiab: N=93,176
Inclusion by Chiro: N=22,994
Inclusion by BSfreq: N=131,486
9 10
Figure 3 secondary ascertainment in nDr by primary ascertainment source, for inclusions in nDr from 1997 through 2011.
Abbreviations: antiDiab, antidiabetic drug; Bsfreq, frequency of blood sugar measurement; Chiro, chiropody; DMdiag, diagnoses of diabetes; nDr, national Diabetes register.
Table 2 Delay (in years) between date of inclusion in nDr and the operational date of diagnosis
Delay (in years) NDR inclusion before 1997 NDR inclusion 1997–2011 (incl) Total
Number % Number % Number %
no delay 106,142 68.2 335,306 98.4 441,448 88.9
0, delay ,1 2,551 1.6 2,489 0.7 5,040 1.0
1# delay ,5 13,860 8.9 1,140 0.3 15,000 3.0
5# delay ,10 17,470 11.2 383 0.1 17,853 3.6
10# delay 15,717 10.1 1,456 0.4 17,173 3.5
all persons 155,740 100.0 340,774 100.0 496,514 100.0
Abbreviation: nDr, national Diabetes register.
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the predictive performance of the “BSfreq” algorithms. 
Our results show that the segment of registrants ascertained 
by “BSfreq” has a substantially lower probability, at about 
50%, of being ascertained subsequently by a secondary 
source. This finding suggests that the group of persons 
ascertained exclusively by “BSfreq”, to some extent, contains 
persons with blood sugar examined without having clinically 
diagnosed diabetes. According to a “worst-case” scenario, 
50% of those 40% of registrants that are ascertained by 
“BSfreq” do not have diabetes; this corresponds to about 
20% of the total population registered in NDR.
In a recent study, a regional algorithm based on informa-
tion on glycosylated hemoglobin (HbA
1c
) measurements as 
a supplementary ascertainment source for the identification 
of persons with diabetes was compared with the algorithm 
used by NDR.8 Based on an analysis of ascertainment pat-
terns in about 14,000 persons ascertained jointly by the 
two algorithms, it was estimated that about 21% of persons 
ascertained by means of “BSfreq” in NDR may not have 
diagnosed diabetes but have their blood glucose examined 
frequently for other reasons. This estimate is close to the 
one presented above, which was obtained by a completely 
different approach. Furthermore, almost 700 persons were 
identified by the regional algorithm as having at least one 
elevated measurement of HbA
1c
 diagnostic of diabetes but 
without being registered with NDR.8 Taking these findings as 
representing ascertainment failure in NDR, a proportionate 
analysis suggests the estimated completeness of diagnosed 
diabetes in NDR to be 93%–95%. Although a full systematic 
analysis of the completeness of ascertainment has been diffi-
cult because of differences in the definitions of the underlying 
patient populations, it is possible to perform formal analysis 
for specific segments. Thus, applying capture–recapture 
methods of analysis to the data in Table 1 of Nielsen et al8 for 
ascertainment by “AntiDiab” and “DMdiag”, the complete-
ness of ascertainment in NDR is estimated at 95.8% (95% 
confidence interval [CI] 95.4%–96.3%) and 97.8% (95% CI 
97.4%–98.6%), respectively.
Whereas the completeness of ascertained diagnosed dia-
betes in NDR may be 95% or higher, a substantial proportion, 
possibly amounting to about 20%, of the persons registered 
with NDR may have been falsely included by means of 
frequent measurement of blood glucose. In June 2012, the 
Danish National Board of Health decided to accept an HbA
1c
 
level above 6.5% as a diagnostic criterion for diabetes. If 
readings of HbA
1c
 measurements will be accessible at the 
national level in the future, it should be considered to revise 
the algorithm for inclusion in NDR accordingly.
In terms of a full assessment of the performance of the 
algorithm of inclusion in NDR, the completeness of ascer-
tainment is interpretable as the sensitivity, which we estimate 
to be 95% or higher. If further assumed that some 20% of 
the registrants in NDR do not have diabetes, the positive 
predictive value of ascertainment is about 80%. Applying 
a sensitivity at 95% and a positive predictive value at 80% 
in a scenario with a total population like the Danish, with 
some six million inhabitants and an annual number of new 
inclusions in NDR at 30,000, yields an estimated specificity 
(ie, the proportion of the total population without diabetes 
and that not ascertained by NDR) at 99.9%.
Date of inclusion in nDr  
versus operationally defined  
date of diagnosis of diabetes
Since the date of clinical diagnosis of diabetes cannot be 
recorded in NDR, it is necessary to use the date of inclusion 
as a proxy. This must be done with due reservation because 
in most cases, the clinical diagnosis may have been estab-
lished before inclusion in NDR.4 The impact of this form of 
bias may be reduced by searching for the earliest possible 
registration of diabetes-related contacts in the source reg-
isters, notably DNPaR. As per the current NDR algorithm, 
all hospital contacts closed before 1990 are ignored.13 The 
reasons for this are not obvious, but the ignorance will 
enhance bias when using the date of inclusion in NDR as a 
proxy for the date of diagnosis of diabetes. Since our study 
takes account of all hospital activities, regardless of time, 
we can show that by ignoring contacts in DNPaR before 
1990, more than 10% of the registrants have a delay in the 
operationally defined date of diagnosis. The delay affects 
more than 30% of the registrants with inclusion date before 
1997 and is substantial, representing 10 years or even more 
for about 10% of the persons included in NDR before 1997. 
While this may not affect the completeness of ascertainment 
in NDR, it introduces a bias, particularly in investigations 
that involve the study of diabetes duration and the impact of 
diabetes duration over time.
Our study also has identif ied that persons may be 
included in NDR after death. To explore on this finding, 
we investigated further the timing of inclusion in NDR. It 
appears that for patients primarily ascertained by “DMdiag” 
and by “AntiDiab”, the inclusion dates seem distributed 
by random, albeit with relatively fewer, inclusions during 
weekends. In contrast, primary ascertainment by “Chiro” 
is systematically associated with inclusion on Wednesdays, 
whereas primary ascertainment by “BSfreq” is associated 
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with inclusion also on Wednesday, however with possible 
spacing between Wednesdays in intervals of up to 4 weeks 
or even more. Thus, it is likely that for inclusion by methods 
using contacts with health care providers in the primary 
health care sector, the inclusion date in NDR represents the 
date of reimbursement from the National Health Service to 
the health care provider, rather than the date of actual provi-
sion of service. Accordingly, a limited number of patients 
have died in the interval between the date of contact and the 
date of reimbursement. This element of the NDR algorithm 
enhances the bias when using date of inclusion in NDR as a 
proxy for date of diagnosis.
The present study has demonstrated how administrative 
changes may influence inclusion in NDR. The number of 
inclusions by “Chiro” as the primary source is limited but 
shows a distinct peak for the period 2002–2004 and again 
for the year 2011. These peaks coincide with periods during 
which agreements between the chiropodists and the National 
Health Service were in effect concerning reimbursement of 
expenses of chiropody for diabetic patients. In fact, the most 
recent summary report from NDR15 shows a relative decrease 
in the number of new inclusions for the year 2012, which 
may be interpreted as a compensation for the relatively steep 
increase in 2011. Such fluctuations must be interpreted with 
appropriate caution to the extent that the inclusion rate in 
NDR is used as a proxy for the incidence rate of diabetes.
Conclusion and recommendations
NDR represents a novel initiative by which unique opportuni-
ties have been created for the monitoring of the basic epide-
miological characteristics of diabetes as well as for further 
in-depth studies on the epidemiological and public health 
aspects of diabetes in Denmark. Comparisons with other 
samples of diabetic patients have suggested that NDR may 
perform with a high level of completeness of ascertainment.8 
Even though, our study has identified a range of issues that 
may question other aspects of the validity of NDR, with cor-
responding consequences for the use of NDR for research 
purposes. Some of these issues may be resolved by relatively 
simple changes in the NDR algorithm. Specifically, we recom-
mend the following: 1) In the search for qualifying contacts 
in DNPaR, the NDR algorithm should include the content of 
the total DNPaR, rather than being limited to contacts after 
1990. This simple measure will reduce substantially the bias 
in the operationally defined start of the diabetes course that 
preferentially exists for persons with inclusion date before 
1997. 2) The set of diagnostic codes used in the NDR should 
be reviewed carefully and updated on a periodic basis with 
current and new relevant diagnostic codes and intervention 
codes specific for diabetes, as suggested in the supplemen-
tary material of this paper. While it may have limited impact 
only concerning the number of persons identified, such an 
improvement facilitates the establishment of a more qualified 
date of inclusion. 3) For inclusion by means of “BSfreq” and 
“Chiro”, the true date of encounter, if available, in the Danish 
National Health Service Register should be used, rather than 
using the date of reimbursement. This will further support 
the establishment of a more qualified date of inclusion, and 
at the same time, the strikingly invalid feature of including 
persons after their death will be avoided. 4) As soon as results 
of HbA
1c
 measurements may become available as part of 
a future nationwide Danish laboratory database, the NDR 
algorithm should switch to rely upon the identification of 
measurements of elevated HbA
1c
, instead of the frequency of 
blood glucose measurements. Such a switch will significantly 
reduce the false inclusion in NDR of persons with frequent 
blood glucose measurements for other clinical reasons than 
diabetes control. 5) Until the NDR algorithm has been further 
improved according to the recommendations presented here, 
we suggest performing sensitivity analyses with respect to the 
segment of persons ascertained by “BSfreq”, in studies that 
make use of the content of NDR.
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Table S1 Diagnosis codes and intervention codes used for the identification of diabetes-related hospital contacts
Code Code category Code text
24900 ICD8 – disease classification insulin-dependent diabetes mellitus, without complications
24901 ICD8 – disease classification Cataract, retinopathy in insulin-dependent diabetes
24902 ICD8 – disease classification Diabetic nephropathy, Kimmelstiel–Wilson syndrome, insulin-dependent diabetes
24903 ICD8 – disease classification neuropathy, diabetic polyneuritis, insulin-dependent diabetes
24904 ICD8 – disease classification Diabetic angiopathy in extremities, insulin-dependent diabetes
24905 ICD8 – disease classification Diabetic gangrene, insulin-dependent diabetes
24906 ICD8 – disease classification Diabetic coma without ketonuria, insulin-dependent diabetes
24907 ICD8 – disease classification Diabetic coma (incl precoma), insulin-dependent diabetes
24908 ICD8 – disease classification Insulin-dependent diabetes mellitus, with complications not otherwise specified
24909 ICD8 – disease classification insulin-dependent diabetes mellitus
25000 ICD8 – disease classification insulin independent diabetes mellitus, without complications
25001 ICD8 – disease classification Cataract, retinopathy in insulin independent diabetes
25002 ICD8 – disease classification Diabetic nephropathy, Kimmelstiel–Wilson syndrome, insulin independent diabetes
25003 ICD8 – disease classification neuropathy, diabetic polyneuritis, insulin independent diabetes
25004 ICD8 – disease classification Diabetic angiopathy in extremities, insulin independent diabetes
25005 ICD8 – disease classification Diabetic gangrene, insulin independent diabetes
25006 ICD8 – disease classification Diabetic coma without ketonuria, insulin independent diabetes
25007 ICD8 – disease classification Diabetic coma (incl precoma), insulin independent diabetes
25008 ICD8 – disease classification Insulin independent diabetes mellitus, with complications not otherwise specified
25009 ICD8 – disease classification insulin independent diabetes mellitus
BBha National Intervention Classification Peroral diabetes treatment
BBha0 National Intervention Classification Treatment with peroral antidiabetic agents
BBha00 National Intervention Classification Treatment with agents stimulating insulin production
BBha01 National Intervention Classification Treatment with glucose-lowering antidiabetic agents
BBhF0 National Intervention Classification insulin treatment
BBhF00 National Intervention Classification insulin treatment, mono- or dual therapy
BBhF01 National Intervention Classification insulin treatment, basal and bolus therapy
BBhF02 National Intervention Classification insulin pump treatment
BBKB National Intervention Classification instruction in injecting insulin
BUBE0 National Intervention Classification Diabetes diet
BUBE00 National Intervention Classification Diabetes diet, type 1 diabetes
BUBE01 National Intervention Classification Diabetes diet, type 2 diabetes
BUFa National Intervention Classification Dietary instruction in relation to diabetes
BUFa0 National Intervention Classification Dietary instruction in relation to type 1 diabetes
BUFa00 National Intervention Classification initial dietary instruction in relation to type 1 diabetes
BUFa01 National Intervention Classification Follow-up dietary instruction in relation to type 1 diabetes
BUFa1 National Intervention Classification Dietary instruction in relation to type 2 diabetes
BUFa10 National Intervention Classification initial dietary instruction in relation to type 2 diabetes
BUFa11 National Intervention Classification Follow-up dietary instruction in relation to type 2 diabetes
BUFa3 National Intervention Classification Dietary instruction in relation to pregnant women with type 1 diabetes
BUFa30 National Intervention Classification initial dietary instruction in relation to pregnant women with type 1 diabetes
BUFa31 National Intervention Classification Follow-up dietary instruction in relation to pregnant women with type 1 diabetes
DE10 ICD10 – disease classification Type 1 diabetes
DE100 ICD10 – disease classification Type 1 diabetes with coma
DE100a ICD10 – disease classification Diabetic coma, hyperosmolar in iDDM
DE100B ICD10 – disease classification Diabetic coma in iDDM with ketoacidosis
DE100C ICD10 – disease classification Diabetic coma in iDDM without ketoacidosis
DE100D ICD10 – disease classification Diabetic coma, hyperglycemic in iDDM
DE100E ICD10 – disease classification Diabetic coma, hypoglycemic in iDDM
DE100F ICD10 – disease classification insulin-dependent diabetes with diabetic coma
DE101 ICD10 – disease classification Type 1 diabetes with ketoacidosis
DE102 ICD10 – disease classification Type 1 diabetes with renal complication
DE103 ICD10 – disease classification Type 1 diabetes with eye complication
DE104 ICD10 – disease classification Type 1 diabetes with neurological complication
(Continued)
Supplementary material
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Table S1 (Continued)
Code Code category Code text
DE105 ICD10 – disease classification Type 1 diabetes with complications in peripheral vascular system
DE105a ICD10 – disease classification Type 1 diabetes with peripheral angiopathy
DE105B ICD10 – disease classification Type 1 diabetes with foot ulcer
DE105C ICD10 – disease classification Type 1 diabetes with gangrene
DE105D ICD10 – disease classification Type 1 diabetes with microangiopathy
DE106 ICD10 – disease classification Type 1 diabetes with other complication
DE107 ICD10 – disease classification Type 1 diabetes with multiple complications
DE108 ICD10 – disease classification Type 1 diabetes with complication Uns
DE109 ICD10 – disease classification Type 1 diabetes without complications
DE109a ICD10 – disease classification Type 1 diabetes Uns
DE11 ICD10 – disease classification Type 2 diabetes
DE110 ICD10 – disease classification Type 2 diabetes with coma
DE110a ICD10 – disease classification Diabetic coma in niDDM without ketoacidosis
DE110B ICD10 – disease classification Diabetic coma, hypoglycemic in niDDM
DE110C ICD10 – disease classification Diabetic coma, hyperosmolar in niDDM
DE110D ICD10 – disease classification Diabetic coma, hyperglycemic in niDDM
DE110E ICD10 – disease classification Diabetic coma in niDDM with ketoacidosis
DE111 ICD10 – disease classification Type 2 diabetes with ketoacidosis
DE112 ICD10 – disease classification Type 2 diabetes with renal complication
DE113 ICD10 – disease classification Type 2 diabetes with eye complication
DE114 ICD10 – disease classification Type 2 diabetes with neurological complication
DE115 ICD10 – disease classification Type 2 diabetes with complications in peripheral vascular system
DE115a ICD10 – disease classification Type 2 diabetes with peripheral angiopathy
DE115B ICD10 – disease classification Type 2 diabetes with foot ulcer
DE115C ICD10 – disease classification Type 2 diabetes with gangrene
DE115D ICD10 – disease classification Type 2 diabetes with microangiopathy
DE116 ICD10 – disease classification Type 2 diabetes with other complication
DE117 ICD10 – disease classification Type 2 diabetes with multiple complications
DE118 ICD10 – disease classification Type 2 diabetes with complication Uns
DE119 ICD10 – disease classification Type 2 diabetes without complications
DE119a ICD10 – disease classification Type 2 diabetes Uns
DE12 ICD10 – disease classification Malnutrition-related diabetes
DE120 ICD10 – disease classification Malnutrition-related diabetes with coma
DE120a ICD10 – disease classification Diabetic coma, hyperglycemic in malnutrition-related diabetes
DE120B ICD10 – disease classification Diabetic coma, hypoglycemic in malnutrition-related diabetes
DE120C ICD10 – disease classification Diabetic coma in malnutrition-related diabetes with ketoacidosis
DE120D ICD10 – disease classification Diabetic coma in malnutrition-related diabetes without ketoacidosis
DE120E ICD10 – disease classification Diabetic coma, hyperosmolar in malnutrition-related diabetes
DE121 ICD10 – disease classification Malnutrition-related diabetes with ketoacidosis
DE122 ICD10 – disease classification Malnutrition-related diabetes with renal complication
DE123 ICD10 – disease classification Malnutrition-related diabetes with eye complication
DE124 ICD10 – disease classification Malnutrition-related diabetes with neurological complication
DE125 ICD10 – disease classification Malnutrition-related diabetes with complications in peripheral vascular system
DE125a ICD10 – disease classification Malnutrition-related diabetes with peripheral angiopathy
DE125B ICD10 – disease classification Malnutrition-related diabetes with foot ulcer
DE125C ICD10 – disease classification Malnutrition-related diabetes with gangrene
DE125D ICD10 – disease classification Malnutrition-related diabetes with microangiopathy
DE126 ICD10 – disease classification Malnutrition-related diabetes with other complication
DE127 ICD10 – disease classification Malnutrition-related diabetes with multiple complications
DE128 ICD10 – disease classification Malnutrition-related diabetes with complication Uns
DE129 ICD10 – disease classification Malnutrition-related diabetes without complications
DE13 ICD10 – disease classification Other forms of diabetes
DE130 ICD10 – disease classification Other form of diabetes with coma
DE131 ICD10 – disease classification Other form of diabetes with ketoacidosis
DE132 ICD10 – disease classification Other form of diabetes with renal complication
DE133 ICD10 – disease classification Other form of diabetes with eye complication
DE134 ICD10 – disease classification Other form of diabetes with neurological complication
(Continued)
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Table S1 (Continued)
Code Code category Code text
DE135 ICD10 – disease classification Other form of diabetes with complications in peripheral vascular system
DE135a ICD10 – disease classification Other form of diabetes with peripheral angiopathy
DE135B ICD10 – disease classification Other form of diabetes with foot ulcer
DE135C ICD10 – disease classification Other form of diabetes with gangrene
DE135D ICD10 – disease classification Other form of diabetes with microangiopathy
DE136 ICD10 – disease classification Other form of diabetes with other complication
DE137 ICD10 – disease classification Other form of diabetes with multiple complications
DE138 ICD10 – disease classification Other form of diabetes with complication Uns
DE139 ICD10 – disease classification Other form of diabetes without complications
DE14 ICD10 – disease classification Unspecified diabetes
DE140 ICD10 – disease classification Diabetes Uns with coma
DE140a ICD10 – disease classification Diabetic coma in malnutrition-related diabetes
DE140B ICD10 – disease classification Diabetic coma, hyperglycemic in unspecified diabetes
DE140C ICD10 – disease classification Diabetic coma, hyperosmolar in unspecified diabetes
DE140D ICD10 – disease classification Diabetic coma, hypoglycemic in unspecified diabetes
DE141 ICD10 – disease classification Diabetes Uns with ketoacidosis
DE142 ICD10 – disease classification Diabetes Uns with renal complication
DE143 ICD10 – disease classification Diabetes Uns with eye complication
DE144 ICD10 – disease classification Diabetes Uns with neurological complication
DE145 ICD10 – disease classification Diabetes Uns with complications in peripheral vascular system
DE145a ICD10 – disease classification Diabetes Uns with peripheral angiopathy
DE145B ICD10 – disease classification Diabetes Uns with foot ulcer
DE145C ICD10 – disease classification Diabetes Uns with gangrene
DE145D ICD10 – disease classification Diabetes Uns with microangiopathy
DE146 ICD10 – disease classification Diabetes Uns with other complication
DE147 ICD10 – disease classification Diabetes Uns with multiple complications
DE148 ICD10 – disease classification Diabetes Uns with complication Uns
DE149 ICD10 – disease classification Diabetes Uns without complications
DE159 ICD10 – disease classification hypoglycemic coma Uns
DE159a ICD10 – disease classification insulin shock
Dg632 ICD10 – disease classification Diabetic polyneuropathy
Dh280 ICD10 – disease classification Diabetic cataract
Dh360 ICD10 – disease classification Diabetic retinopathy Uns
Dh360a ICD10 – disease classification simplex retinopathy iDDM
Dh360B ICD10 – disease classification Proliferative retinopathy iDDM
Dh360C ICD10 – disease classification simplex retinopathy niDDM
Dh360D ICD10 – disease classification Proliferative retinopathy niDDM
Dh360E ICD10 – disease classification Diabetic maculopathy iDDM
Dh360F ICD10 – disease classification Diabetic maculopathy niDDM
Dh360h ICD10 – disease classification simplex diabetic retinopathy
Dh360J ICD10 – disease classification Proliferative diabetic retinopathy
Dh360K ICD10 – disease classification Diabetic maculopathy
DZ135a1 ICD10 – disease classification screening for diabetic retinopathy
Abbreviations: ICD, International Classification of Disease; IDDM, insulin-dependent diabetes mellitus; NIDDM, non-insulin-dependent diabetes mellitus; UNS, unspecified.
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